Read + Share
Amedeo Smart
Independent Medical Education
Yang K, Yang B, Zhou Y, Huang Q, et al. Promising activity of Selinexor in the treatment of a patient with refractory NUP98-NSD1+/FLT3-ITD + acute myeloid leukemia. Ann Hematol 2025 Mar 18. doi: 10.1007/s00277-025-06312.PMID: 40100393
Email
LinkedIn
Privacy Policy